about
Celcuity Inc is a clinical-stage biotechnology company developing targeted therapies for multiple solid tumors. Its candidate, gedatolisib, is a kinase inhibitor of the PI3K/AKT/mTOR (PAM) pathway, binding all class I PI3K isoforms and mTORC1/2, offe...
Read More
70.38
-1.72
(-2.39%)
422.7K
XNAS Volume
XNAS 05 Oct, 2026 11:44 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Celcuity Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..